Clinical Trials Sponsored by Jacobus Pharmaceutical
Total 19646 results
-
Chugai PharmaceuticalCompletedLiver Cirrhosis | Chronic Hepatitis CJapan
-
JW PharmaceuticalCompletedErectile DysfunctionKorea, Republic of
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Chugai PharmaceuticalCompletedPolyarticular Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Lotus PharmaceuticalCompletedMigraine Without Aura | Migraine With AuraTaiwan
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Zeria PharmaceuticalTerminated
-
Kissei Pharmaceutical Co., Ltd.Maruishi PharmaceuticalCompleted
-
Chugai PharmaceuticalNot yet recruitingAntiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)United States, Japan
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States
-
Chugai PharmaceuticalRecruitingSolid TumorUnited States, Japan
-
Xintian PharmaceuticalRecruitingBenign Prostatic Hyperplasia With Lower Urinary Tract SymptomsChina
-
Chugai PharmaceuticalNot yet recruitingPostmenopausal OsteoporosisChina
-
Chugai PharmaceuticalRecruitingHepatocellular Carcinoma (HCC)Taiwan, Japan
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
JW PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A Without InhibitorKorea, Republic of
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
BioMarin PharmaceuticalEnrolling by invitationHemophilia AUnited Kingdom, United States
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
JW PharmaceuticalCompleted
-
Xintian PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompleted
-
Xintian PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuriaItaly, Spain, United Kingdom, Germany
-
Zeria PharmaceuticalCompleted
-
Chugai PharmaceuticalCompletedHealthy VolunteersNetherlands
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
Bukwang PharmaceuticalCompleted
-
Allysta PharmaceuticalCompleted
-
Zeria PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedHyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) DeficiencySweden, France, Italy, Spain, Germany, Netherlands, Austria, Slovakia, Portugal
-
Zeria PharmaceuticalCompletedCervical CancerJapan, Korea, Republic of, Malaysia, Singapore, Taiwan, Thailand, Vietnam
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, Germany, Spain, United Kingdom, Japan, Turkey
-
JW PharmaceuticalActive, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Chugai PharmaceuticalCompleted
-
JW PharmaceuticalCompletedHypercholesterolemia
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)United States, France, Australia, Germany, Ireland, Austria, Belgium, Italy, Lithuania, Netherlands, Portugal, Sweden, United Kingdom
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedAchondroplasiaSpain, Denmark, Italy, Austria, Germany, Sweden
-
JW PharmaceuticalCompletedIron Deficiency AnemiaKorea, Republic of